Oruka Therapeutics, Inc. (ORKA) Operating income 2016–2025
Oruka Therapeutics, Inc. (ORKA) annual operating income history from SEC filings — each fiscal year as reported.
-$122.1MFY2025 · since FY2016: -$16.6M → -$122.1M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$122.1M | — |
| FY2023 | -$7.3M | +31.1% |
| FY2022 | -$10.6M | +45.2% |
| FY2021 | -$19.3M | -98.0% |
| FY2020 | -$9.8M | -68.0% |
| FY2019 | -$5.8M | +28.4% |
| FY2018 | -$8.1M | +56.6% |
| FY2017 | -$18.7M | -12.6% |
| FY2016 | -$16.6M | — |
Source: SEC XBRL filings · For reference only · Not investment advice